Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.2 |
mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |
mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |